ID   V79MZh2D6*17-H
AC   CVCL_F0FQ
RX   Patent=US20050130116;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2625; CYP2D6 (Note=With p.Thr107Ile (c.320C>T) and p.Arg296Cys (c.886C>T). Allele CYP2D6*17).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
RX   Patent=US20050130116;
RA   Doehmer, Johannes
RA   Krebsfaenger, Niels
RA   Eichelbaum, Michel F.
RA   Zanger, Ulrich M.
RT   "Stable expression of polymorphous forms of human cytochrome p450
RT   2D6.";
RL   Patent number US20050130116, 16-Jun-2005.
//